| Literature DB >> 36012591 |
Anahit Sedrakyan1, Zhanna Ktsoyan1, Karine Arakelova1, Zaruhi Gevorgyan2, Magdalina Zakharyan1, Shoghik Hakobyan1, Alvard Hovhannisyan1, Arsen Arakelyan1, Rustam Aminov3.
Abstract
In this work, we analysed human isolates of nontyphoidal Salmonella enterica subsp. enterica (NTS), which were collected from salmonellosis cases in Armenia from 1996 to 2019. This disease became a leading food-borne bacterial infection in the region, with the younger age groups especially affected. The isolates were characterised by serotyping, Enterobacterial Repetitive Intergenic Consensus (ERIC-PCR) typing, and whole genome sequencing (WGS). The main serotypes were S. Typhimurium, S. Enteritidis, and S. Arizonae. ERIC-PCR indicated a high degree of clonality among S. Typhimurium strains, which were also multidrug-resistant and produced extended spectrum beta-lactamases. During the study period, the frequency of S. Typhimurium and S. Arizonae isolations decreased, but with the increase in S. Enteritidis and other NTS. A total of 42 NTS isolates were subjected to WGS and explored for virulence-related traits and the corresponding genetic elements. Some virulence and genetic factors were shared by all NTS serotypes, while the main differences were attributed to the serotype-specific diversity of virulence genes, SPIs, virulence plasmids, and phages. The results indicated the variability and dynamics in the epidemiology of salmonellosis and a high virulence potential of human NTS isolates circulating in the region.Entities:
Keywords: ERIC-PCR typing; SPIs; Salmonella virulence plasmids; WGS; non-typhoidal Salmonella; prophages; virulence-related genes
Mesh:
Substances:
Year: 2022 PMID: 36012591 PMCID: PMC9409446 DOI: 10.3390/ijms23169330
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1The total number of confirmed non-typhoidal Salmonella infections in Armenia and the proportion of age groups under 14 and 18 years old, according to the Statistical Committee of the Republic of Armenia data [23].
Figure 2Serotypes of 1423 human non-typhoidal Salmonella (NTS) isolates recovered from patients admitted to the Nork Infectious Clinical Hospital (Ministry of Health, Armenia) in 2011–2017.
Figure 3Dendrogram of ERIC-PCR fingerprinting profiles of 112 human NTS isolates from Armenia, with sequence types (MLST) and AMR phenotypes. The dendrogram was generated with Dice coefficient and the UPGMA clustering method. Colour keys: blue nodes represent resistant phenotype to antimicrobial agent, grey nodes represent intermediate susceptibility to antimicrobial agent, black nodes represent positive isolates for MDR or ESBL phenotype. Abbreviations: ERIC, Enterobacterial Repetitive Intergenic Consensus; NTS, non-typhoidal Salmonella; AMR, antimicrobial resistance; AM, ampicillin; AMC, amoxicillin-clavulanic acid; AZM, azithromycin; CRO, ceftriaxone; CAZ, ceftazidime; IPM, imipenem; CIP, ciprofloxacin; NA, nalidixic acid; C, chloramphenicol; GM, gentamicin; STS, streptomycin; SSS, sulfonamide; STX, trimethoprim-sulfamethoxazole; TE, tetracycline; MDR, multidrug resistant; ESBL, extended spectrum beta-lactamases. *—Identified based on WGS data.
Figure 4Serotypes and sequence types (ST) of 42 human non-typhoidal Salmonella (NTS) isolates from Armenia determined by whole genome sequencing (WGS). MDR, all phenotypically multidrug-resistant.
Prevalence of the serotype-specific virulence-related genes in human non-typhoidal Salmonella (NTS) isolates from Armenia identified by VFanalyzer [28].
| Genes | Serotype of NTS (Number of Isolates) | Virulence Factor Class | |||||
|---|---|---|---|---|---|---|---|
| Typhimurium | Enteritidis | Derby | Agona | Kentucky | Newport | ||
|
| - | 7 | - | 1 | 1 | 1 | Fimbrial adherence |
|
| - | 7 | 2 | - | - | 1 | |
|
| 4 | 6 | - | - | - | - | |
|
| 30 | 7 | 2 | - | 1 | 1 | |
|
| - | 7 | - | - | - | - | |
|
| - | - | 2 | 1 | - | - | |
|
| 30 | - | - | 1 | - | - | |
|
| 30 | - | - | 1 | 1 | - | |
|
| 30 | - | - | 1 | 1 | - | |
|
| 30 | - | - | 1 | - | - | |
|
| - | 7 | 2 | 1 | 1 | 1 | |
|
| 30 | - | - | 1 | 1 | 1 | |
|
| - | - | - | - | 1 | - | |
|
| - | - | - | - | 1 | - | |
|
| 30 | 7 | - | 1 | - | 1 | Nonfimbrial adherence determinants |
|
| - | 7 | - | - | - | 1 | T3SS1 translocated effector |
|
| 30 | - | - | - | - | - | T3SS2 translocated |
|
| - | 7 | 2 | 1 | 1 | 1 | |
|
| 4 | 6 | - | - | - | - | |
|
| 30 | 7 | - | - | - | - | |
|
| 30 | 7 | 2 | 1 | 1 | - | |
|
| 30 | 7 | 2 | - | 1 | 1 | Macrophage inducible gene |
|
| 4 | 6 | - | - | - | - | |
|
| 30 | 7 | - | - | - | - | Stress adaptation |
|
| 4 | 6 | - | - | - | - | Serum resistance |
|
| 4 | 6 | - | - | - | - | Toxin |
|
| - | - | 2 | - | - | - | Autotransporter |
|
| - | - | - | - | 1 | - | |
|
| - | - | - | - | 1 | - | Adherence/K88 fimbriae ( |